Luwei Han
Luwei Han publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations and Cancer therapeutics and mechanisms.
- World rank
- #5,832,451 of 7,710,434 ranked researchers
- Rank in China
- #833,521 of 978,568
- Works
- 17
- Citations
- 130
- Citations per work
- 7.6
What does Luwei Han research?
Luwei Han's work is mostly in Medicine (25%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else637.5%
- Life Sciences529.1%
- Health Sciences425.0%
- Medicine425.0%
- Physical Sciences18.4%
- Chemistry14.2%
- Earth and Planetary Sciences14.2%
- 1Molecular Biology21% of their works
- 2Pulmonary and Respiratory Medicine15% of their works
- 3Oncology10% of their works
- 4Immunology8% of their works
- 5Oceanography4% of their works
- 6Organic Chemistry4% of their works
Research topics
Which keywords describe Luwei Han's research?
The keywords of their largest research topics: Chemotherapy, Targeted Therapy, ALK Inhibitors, Cetuximab, EGFR Mutations, KRAS Mutations, DNA and Endoscopic Resection.
- Tumor Targeting
- Cancer
- Tumorigenesis
- Ricin Poisoning
- Immunotoxin
- Endoscopic Resection
- KRAS Mutations
- Cetuximab
- Targeted Therapy
- Chemotherapy
- ALK Inhibitors
- EGFR Mutations
- DNA
- Gastric Cancer
- Pim Oncogenes
- Topoisomerases
- Bacterial Therapy
- Long Noncoding RNAs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Chemotherapy73 topics
- Targeted Therapy52 topics
- ALK Inhibitors31 topic
- Cetuximab31 topic
- EGFR Mutations31 topic
- KRAS Mutations31 topic
- DNA21 topic
- Endoscopic Resection21 topic
- Gastric Cancer21 topic
- Immunotoxin21 topic
- Pim Oncogenes21 topic
- Ricin Poisoning21 topic
- Topoisomerases21 topic
- Tumorigenesis21 topic
- Bacterial Therapy11 topic
- Cancer11 topic
- Long Noncoding RNAs11 topic
- Tumor Targeting11 topic
Where does Luwei Han work?
Luwei Han's main affiliation in the publication record is Simcere Pharmaceutical (China), China.
How many publications and citations does Luwei Han have?
OpenAlex counts 17 works and 130 citations for Luwei Han, an h-index of 6, ranking #5,832,451 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Luwei Han. Posts are plain text and can be reported.